Affimed NV - חוב לטווח קצר של החברה AFMD

This daily price chart for Affimed (AFMD) on the GURU.Markets platform reflects the 0.00 metric. The business is critically dependent on success in lymphoma treatment, while liquidity remains sufficient. The development of immune regulators relies on streamlined supply chains, which reduces costs. Particular attention is paid to the transportation of biologics, where strict adherence to shipping conditions guarantees therapeutic efficacy.

This indicator measures the aggregate of liabilities maturing within twelve months, allowing an investor to filter out market volatility via debt with a maturity of up to one year and assess the issuer's actual solvency. For Affimed (AFMD), this metric is critical, as the outsourcing of late-stage development and production of biologics shifts capital expenditures into the category of short-term operational payments to counterparties.